Matthew J. O'Connell

733 total citations
27 papers, 517 citations indexed

About

Matthew J. O'Connell is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Matthew J. O'Connell has authored 27 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Matthew J. O'Connell's work include Colorectal Cancer Treatments and Studies (4 papers), Inflammatory mediators and NSAID effects (3 papers) and Acute Myeloid Leukemia Research (2 papers). Matthew J. O'Connell is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Inflammatory mediators and NSAID effects (3 papers) and Acute Myeloid Leukemia Research (2 papers). Matthew J. O'Connell collaborates with scholars based in United States, Australia and Ireland. Matthew J. O'Connell's co-authors include Stephen A. Osmani, Norman Morris, A.H. Osmani, J. J. Mazza, Martin M. Oken, John Hines, J M Bennett, Donald P. Harrington, Philip B. McGlave and Peter A. Cassileth and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Nature Cell Biology.

In The Last Decade

Matthew J. O'Connell

24 papers receiving 492 citations

Peers

Countries citing papers authored by Matthew J. O'Connell

Since Specialization

Citations

This map shows the geographic impact of Matthew J. O'Connell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. O'Connell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. O'Connell more than expected).

Fields of papers citing papers by Matthew J. O'Connell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. O'Connell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. O'Connell. The network helps show where Matthew J. O'Connell may publish in the future.

Co-authorship network of co-authors of Matthew J. O'Connell

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. O'Connell. A scholar is included among the top collaborators of Matthew J. O'Connell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. O'Connell. Matthew J. O'Connell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimal diuretic dosing strategies following cardiac surgery: a retrospective cohort study 2024 ·Elizabeth O’Connell, Nicola C. Edwards, Matthew J. O'Connell, Bilal H. Kirmani	0
2	Major variation in hepatocellular carcinoma treatment and outcomes in England: a retrospective cohort study 2022 ·Frontline Gastroenterology ·(unknown), Matthew J. O'Connell, Ayman H. Nassar, (unknown), (unknown), (unknown), Timothy Cross	3
3	God's initiative towards man the symbol-maker 2012 ·Proceedings of the Catholic Theological Society of America (Catholic Theological Society of America) ·Matthew J. O'Connell	0
4	1,7-Disubstituted oxyindoles are potent and selective EP3 receptor antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Nian Zhou, (unknown), Matthew J. O'Connell, (unknown), Peng Yu, Wayne E. Zeller, Jun Zhang, (unknown), (unknown), (unknown), (unknown), Þorkell Andrésson, Alex S. Kiselyov, Mark E. Gurney, Jasbir Singh	29
5	Peri-substituted hexahydro-indolones as novel, potent and selective human EP3 receptor antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Matthew J. O'Connell, Wayne E. Zeller, (unknown), Rama K. Mishra, José Luis Ramírez, Alex S. Kiselyov, (unknown), Mark E. Gurney, Jasbir Singh	15
6	A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: Survival results of NSABP Protocol C-07 2008 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), Matthew J. O'Connell, (unknown)	15
7	Mitotic Regulation in Aspergillus Nidulans 2007 ·Novartis Foundation symposium ·N. Ronald Morris, (unknown), Matthew J. O'Connell	1
8	The celebration of the Eucharist : the origin of the rite and the development of its interpretation 1999 ·Project Muse (Johns Hopkins University) ·(unknown), Matthew J. O'Connell	8
9	Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. 1998 ·Journal of Clinical Oncology ·Matthew J. O'Connell, David M. Nagorney, Albert M. Bernath, Georgene Schroeder, (unknown), J A Mailliard, Patrick A. Burch, John S. Bolton, Gerardo Colón‐Otero, James E. Krook	48
10	Locally Recurrent Colorectal Cancer: IOERT and EBRT ±5-FU and Maximal Resection 1997 ·Frontiers of radiation therapy and oncology ·L. L. Gunderson, Michael G. Haddock, Heidi D Nelson, (unknown), R. M. Devine, Jennifer M. Fieck, B. G. Wolff, Roger R. Dozois, Matthew J. O'Connell	12
11	Locally Advanced Primary Colorectal Cancer: IOERT and EBRT ±5-FU 1997 ·Frontiers of radiation therapy and oncology ·L. L. Gunderson, Heidi Nelson, James A. Martenson, Stephen Cha, Michael G. Haddock, R. M. Devine, Jennifer M. Fieck, B. G. Wolff, Roger R. Dozois, Matthew J. O'Connell	2
12	Phase I–II study of pibenzimol hydrochloride (NSC 322921) in advanced pancreatic carcinoma 1991 ·Investigational New Drugs ·Shruti Patel, Larry K. Kvols, Joseph Rubin, Matthew J. O'Connell, J H Edmonson, Matthew M. Ames, J. S. Kovach	24
13	Comparison of Postremission Therapies in Adult Acute Myeloid Leukemia: Preliminary Analysis of an ECOG Study 1990 ·Hämatologie und Bluttransfusion ·Peter A. Cassileth, David P. Harrington, John Hines, Martin M. Oken, J. J. Mazza, Philip B. McGlave, John M. Bennett, Elizabeth Lynch, Matthew J. O'Connell	3
14	Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia. 1988 ·Journal of Clinical Oncology ·Peter A. Cassileth, Donald P. Harrington, John Hines, Martin M. Oken, J. J. Mazza, Philip B. McGlave, J M Bennett, Matthew J. O'Connell	117
15	The reception of Vatican II 1987 ·Catholic University of America Press eBooks ·(unknown), (unknown), (unknown), Matthew J. O'Connell	10
16	Disposition of tricyclic nucleoside-5'-monophosphate in blood and plasma of patients during phase I and II clinical trials. 1986 ·PubMed ·Garth Powis, (unknown), (unknown), Ronald L. Richardson, Matthew J. O'Connell, Larry K. Kvols	11
17	The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience. 1986 ·Journal of Clinical Oncology ·John M. Bennett, Kevin C. Cain, J H Glick, G. J. Johnson, Ediz Z. Ezdinli, Matthew J. O'Connell	54
18	In vitroandin vivoevaluation of cellacephate microcapsules of sodium salicylate prepared by pan coating 1985 ·Journal of Microencapsulation ·Matthew J. O'Connell, P. B. Deasy	2
19	Correlation of surface characteristics with ease of production and in vitro release of sodium salicylate from various enteric coated microcapsules prepared by pan coating 1984 ·Journal of Microencapsulation ·P. B. Deasy, Matthew J. O'Connell	7
20	Book Review: On the Theology of Death 1962 ·Theological Studies ·Matthew J. O'Connell	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact